JPY 909.0
(-0.66%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 1.43 Billion JPY | -86.49% |
2022 | 6.23 Billion JPY | -25.69% |
2021 | 8.45 Billion JPY | 29.67% |
2020 | 6.53 Billion JPY | 131.85% |
2019 | 2.82 Billion JPY | -53.37% |
2018 | 6.04 Billion JPY | 9.83% |
2017 | 5.55 Billion JPY | 48.75% |
2016 | 3.74 Billion JPY | 209.24% |
2015 | 1.18 Billion JPY | 71.96% |
2014 | 687.31 Million JPY | 28.23% |
2013 | 548.05 Million JPY | -23.11% |
2012 | 700.61 Million JPY | -85.28% |
2011 | 1.96 Billion JPY | 2.66% |
2010 | 1.84 Billion JPY | 15.43% |
2009 | 1.7 Billion JPY | 27.47% |
2008 | 851.17 Million JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 307.18 Million JPY | 133.99% |
2023 Q1 | 1.86 Billion JPY | 264.68% |
2023 Q4 | -1.27 Billion JPY | -355.81% |
2023 Q3 | -280.47 Million JPY | -132.47% |
2023 FY | - JPY | -86.49% |
2023 Q2 | 863.7 Million JPY | -53.73% |
2022 Q2 | 4.76 Billion JPY | 119.81% |
2022 Q4 | 511.82 Million JPY | 139.43% |
2022 FY | - JPY | -25.69% |
2022 Q1 | 2.16 Billion JPY | 17.21% |
2022 Q3 | -1.29 Billion JPY | -127.25% |
2021 Q1 | 3 Billion JPY | 243.13% |
2021 Q2 | 1.2 Billion JPY | -59.82% |
2021 Q3 | 2.2 Billion JPY | 82.86% |
2021 Q4 | 1.84 Billion JPY | -16.31% |
2021 FY | - JPY | 29.67% |
2020 Q1 | 1.68 Billion JPY | 751.3% |
2020 Q4 | 876.09 Million JPY | -36.55% |
2020 FY | - JPY | 131.85% |
2020 Q3 | 1.38 Billion JPY | -43.69% |
2020 Q2 | 2.45 Billion JPY | 45.55% |
2019 Q3 | 672.97 Million JPY | -37.49% |
2019 FY | - JPY | -53.37% |
2019 Q1 | 735.2 Million JPY | -12.75% |
2019 Q2 | 1.07 Billion JPY | 46.42% |
2019 Q4 | 197.89 Million JPY | -70.59% |
2018 FY | - JPY | 9.83% |
2018 Q3 | 776.31 Million JPY | -62.67% |
2018 Q4 | 842.62 Million JPY | 8.54% |
2018 Q1 | 2.28 Billion JPY | 171.18% |
2018 Q2 | 2.07 Billion JPY | -9.1% |
2017 FY | - JPY | 48.75% |
2017 Q4 | 843.64 Million JPY | -32.2% |
2017 Q3 | 1.24 Billion JPY | -26.93% |
2017 Q2 | 1.7 Billion JPY | 3.74% |
2017 Q1 | 1.64 Billion JPY | 164.37% |
2016 Q1 | 1.13 Billion JPY | 249.87% |
2016 FY | - JPY | 209.24% |
2016 Q2 | 1.22 Billion JPY | 8.43% |
2016 Q3 | 626.25 Million JPY | -48.9% |
2016 Q4 | 620.89 Million JPY | -0.86% |
2015 Q2 | 159.37 Million JPY | -66.61% |
2015 Q3 | 145.69 Million JPY | -8.58% |
2015 FY | - JPY | 71.96% |
2015 Q1 | 477.3 Million JPY | -15.52% |
2015 Q4 | 323.05 Million JPY | 121.73% |
2014 FY | - JPY | 28.23% |
2014 Q4 | 564.98 Million JPY | 2391.19% |
2014 Q3 | -24.65 Million JPY | -141.71% |
2014 Q2 | 59.12 Million JPY | 85.68% |
2014 Q1 | 31.84 Million JPY | -95.49% |
2013 Q4 | 705.49 Million JPY | 1609.92% |
2013 Q1 | -511.44 Million JPY | -211.34% |
2013 Q2 | 354.41 Million JPY | 169.3% |
2013 Q3 | -46.72 Million JPY | -113.18% |
2013 FY | - JPY | -23.11% |
2012 Q3 | -2.34 Billion JPY | -318.2% |
2012 Q2 | 1.07 Billion JPY | -26.78% |
2012 Q1 | 1.46 Billion JPY | 123.06% |
2012 FY | - JPY | -85.28% |
2012 Q4 | 459.34 Million JPY | 119.63% |
2011 Q4 | 656.66 Million JPY | -19.15% |
2011 FY | - JPY | 2.66% |
2011 Q1 | 1.91 Billion JPY | 827.23% |
2011 Q2 | 1.38 Billion JPY | -27.79% |
2011 Q3 | 812.2 Million JPY | -41.23% |
2010 FY | - JPY | 15.43% |
2010 Q1 | 1.5 Billion JPY | 331.75% |
2010 Q2 | 1.53 Billion JPY | 2.17% |
2010 Q3 | 1.4 Billion JPY | -8.47% |
2010 Q4 | 206.41 Million JPY | -85.35% |
2009 Q4 | 348.85 Million JPY | -67.29% |
2009 Q1 | 1.38 Billion JPY | 0.0% |
2009 FY | - JPY | 27.47% |
2009 Q2 | 1.23 Billion JPY | -11.32% |
2009 Q3 | 1.06 Billion JPY | -13.34% |
2008 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Kitanotatsujin Corporation | 1.58 Billion JPY | 9.518% |
Euglena Co., Ltd. | 676 Million JPY | -112.54% |
BEAUTY GARAGE Inc. | 1.96 Billion JPY | 26.876% |
Axas Holdings Co.,Ltd. | 555.75 Million JPY | -158.525% |
C.I. Medical Co.,Ltd. | 4.01 Billion JPY | 64.197% |
Kao Corporation | 154.49 Billion JPY | 99.07% |
Niitaka Co., Ltd. | 1.36 Billion JPY | -4.91% |
Rohto Pharmaceutical Co.,Ltd. | 48.85 Billion JPY | 97.059% |
Shiseido Company, Limited | 106.46 Billion JPY | 98.65% |
Lion Corporation | 42.31 Billion JPY | 96.605% |
Mandom Corporation | 6.69 Billion JPY | 78.552% |
Ivy Cosmetics Corporation | 242.6 Million JPY | -492.239% |
Milbon Co., Ltd. | 7.8 Billion JPY | 81.581% |
Nippon Shikizai, Inc. | 1.28 Billion JPY | -11.501% |
Fancl Corporation | 16.6 Billion JPY | 91.346% |
KOSÉ Corporation | 26.85 Billion JPY | 94.65% |
Cota Co., Ltd. | 2.26 Billion JPY | 36.663% |
HABA Laboratories,Inc. | -1.31 Billion JPY | 209.318% |
C'bon Cosmetics Co.,Ltd. | 171.84 Million JPY | -736.076% |
Pola Orbis Holdings Inc. | 23.17 Billion JPY | 93.801% |
Noevir Holdings Co., Ltd. | 12.24 Billion JPY | 88.266% |
Adjuvant Holdings Co.,Ltd. | 124 Million JPY | -1058.686% |
Almado, Inc. | 983.21 Million JPY | -46.129% |
I-ne CO., LTD. | 4.7 Billion JPY | 69.43% |
Premier Anti-Aging Co., Ltd. | -627 Million JPY | 329.15% |
Liberta Co.,Ltd. | 318.19 Million JPY | -351.542% |
AXXZIA Inc. | 1.28 Billion JPY | -11.68% |
S.T. Corporation | 2.62 Billion JPY | 45.287% |
Kobayashi Pharmaceutical Co., Ltd. | 31.68 Billion JPY | 95.465% |
Earth Corporation | 10.6 Billion JPY | 86.456% |
Sagami Rubber Industries Co., Ltd. | 1.09 Billion JPY | -31.266% |
Asahi Eito Holdings Co.,Ltd. | -573.98 Million JPY | 350.317% |
MTG Co., Ltd. | 4.39 Billion JPY | 67.302% |
TRANSACTION CO.,Ltd. | 5.8 Billion JPY | 75.268% |
SHOBIDO Corporation | 1.11 Billion JPY | -29.416% |
Artnature Inc. | 3.78 Billion JPY | 62.06% |
Pigeon Corporation | 15.8 Billion JPY | 90.91% |
Unicharm Corporation | 178.01 Billion JPY | 99.193% |
Paltac Corporation | 35.92 Billion JPY | 96.0% |
CB GROUP MANAGEMENT Co., Ltd. | 3.28 Billion JPY | 56.263% |